Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-04-17
2007-04-17
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C558S073000
Reexamination Certificate
active
10628649
ABSTRACT:
The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic β-lactamase inhibitors presently available, and which do not possess a β-lactam pharmacophore. These new inhibitors are fully synthetic, allowing ready access to a wide variety of structurally related analogs. Certain embodiments of these new inhibitors also bind bacterial DD-peptidases, thus potentially acting both as β-lactamase inhibitors and as antibiotics.
REFERENCES:
patent: 4565808 (1986-01-01), Andrus et al.
patent: 6608046 (2003-08-01), Besterman et al.
patent: 260241 (1988-03-01), None
patent: 9113891 (1991-09-01), None
patent: 9221702 (1991-12-01), None
Kamivez et al., Phosphorus Sulfur (1978), 4(1), pp. 43-46.
Kang et al., Misaengmul Hakhoechi (1991), 29(6), pp. 353-360.
Goto et al., Sep. Sci. Technol. (1995), 30(1), pp. 89-99.
Cha et al., Bull Korean Chem. Soc. (1994), 15(11), pp. 1001-1003.
Li, N. et al., “Structure-Activity Studies of the Inhibition of Serine Beta-Lactamases by Phosphonate Monoesters”, Bioorg. Med. Chem.; 1997; 5(9)1783-1788, 1997.
Laird, R.M. et al., “Mechanism of Acyl Phosphonate Reactions . . . ”, J. Chem. Soc., Perkin Trans. 2(JCPKBH); (10)1434-6, 1973.
Kazlauskas, R.J. et al., “synthesis of Methoxycarbonyl Phosphate, New Reagent Having . . .”, J. Org. Chem., 50(7)1069-76, 1985.
Li, Naixin, “Inhibition of Serine B-Lactamases by Acyl Phosphonates: A New Source of Inert . . . ”, J. of the American Chemical Society; 120(18)4264-8, 1998.
Pratt, R.F., “Salicyloyl Cyclic Phosphate, a Penicillin-Like Inhibitor of B-Lactamases”, J. of the Amer. Chem. Soc., 120(13)3004-06, 1998.
Song, Y. et al., “Benzylpenicillin Methyl Phosphate. A Penicillin Prodrug . . . ”, Bioorg. Med. Chem. Lett.; 4(10)1225-8, 1994.
Rahil, J. et al., “Phosphonate Monoester Inhibitors of Class A. Beta-Lactamases”, Biochem., 275(3)793-795, 1991.
Cohen, Science, 257:1051-1055, 1992.
Neu, Science, 257:1064-1073, 1992.
Coulton et al., Progress in Medicinal Chemistry, 31:297-349, 1994.
Dudley, Pharmacotherapy, 15:9S-14S, 1995.
Sutherland, Trends Pharmacol. Sci., 12:227-232, 1991.
Chantrenne, Compte. Rend. Trav. Lab. Carlsberg Ser. Chim. 26:297, 1948.
Maracek et al., J. Am. Chem. Soc., 92:917-921, 1970.
Kluger et al., Can. J. Chem., 74:2395-2400.
Waley, “The Cehmistry of B-Lactamase”, Page Ed., Chapman & Hall, London, 198-228, 1992.
Jencks et al., J. Biol. Chem., 234:1272-1279, 1959.
Rahil et al., Chem. Soc. Perkin Trans. 2, 948-950, 1991.
Bruice et al., J. Am. Chem. Soc., 117:12064-12069, 1995.
Montgomery et al., J. Chem. Soc., 4603-4606, 1956.
Wilkinson, Biocehm. J., 80:324-332, 1989.
Govardhan et al., Biocehm., 26:3385-3395, 1987.
Xu et al., Biocehm., 35:3595-3606, 1996.
Davis et al., eds. (1980) J.P. Lippincott Co., Philadelphia, PA.
Molecular Cloning, 2nded., Cold Spring harbor Laboratory Press, 1989.
Bateson et al., Bioorg. & Med. Chem. Lett., 4:1667-1672, 1994.
Besterman Jeffrey M.
Pratt Rex
Rahil Jubrail
Keown & Associates
McKane Joseph K.
Methylgene Inc.
Shiao Robert
LandOfFree
Acyl phosphonate inhibitors of β-lactamases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyl phosphonate inhibitors of β-lactamases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl phosphonate inhibitors of β-lactamases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3774524